279 related articles for article (PubMed ID: 11956030)
1. Retinoids, cisplatin and interferon-alpha in recurrent or metastatic cervical squamous cell carcinoma: clinical results of 2 phase II trials.
Braud AC; Gonzague L; Bertucci F; Genre D; Camerlo J; Gravis G; Goncalves A; Moutardier V; Viret F; Maraninchi D; Viens P
Eur Cytokine Netw; 2002; 13(1):115-20. PubMed ID: 11956030
[TBL] [Abstract][Full Text] [Related]
2. 13-cis-retinoic acid or all-trans-retinoic acid plus interferon-alpha in recurrent cervical cancer: a Southwest Oncology Group phase II randomized trial.
Weiss GR; Liu PY; Alberts DS; Peng YM; Fisher E; Xu MJ; Scudder SA; Baker LH; Moore DF; Lippman SM
Gynecol Oncol; 1998 Dec; 71(3):386-90. PubMed ID: 9887236
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix.
Fiorica J; Holloway R; Ndubisi B; Orr J; Grendys E; Boothby R; DeCesare S; LaPolla J; Hoffman M; Patel J
Gynecol Oncol; 2002 Apr; 85(1):89-94. PubMed ID: 11925125
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
Zanetta G; Fei F; Mangioni C
Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel and cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma.
Adamo V; Ferraro G; Pergolizzi S; Sergi C; Laudani A; Settineri N; Alafaci E; Scimone A; Spano F; Spitaleri G
Oral Oncol; 2004 May; 40(5):525-31. PubMed ID: 15006626
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
Mannel RS; Blessing JA; Boike G
Gynecol Oncol; 2000 Oct; 79(1):64-6. PubMed ID: 11006033
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of the combination of bryostatin-1 and cisplatin in advanced or recurrent carcinoma of the cervix: a New York Gynecologic Oncology Group study.
Nezhat F; Wadler S; Muggia F; Mandeli J; Goldberg G; Rahaman J; Runowicz C; Murgo AJ; Gardner GJ
Gynecol Oncol; 2004 Apr; 93(1):144-8. PubMed ID: 15047228
[TBL] [Abstract][Full Text] [Related]
8. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
Worden FP; Moon J; Samlowski W; Clark JI; Dakhil SR; Williamson S; Urba SG; Ensley J; Hussain MH;
Cancer; 2006 Jul; 107(2):319-27. PubMed ID: 16779801
[TBL] [Abstract][Full Text] [Related]
9. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
[TBL] [Abstract][Full Text] [Related]
10. A phase II study of carboplatin and cisplatin in advanced or recurrent squamous carcinoma of the uterine cervix.
Morris M; Gershenson DM; Burke TW; Mitchell MF; Levenback C; Atkinson N; Wharton JT
Gynecol Oncol; 1994 May; 53(2):234-8. PubMed ID: 8188085
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of neoadjuvant cisplatin, 5-fluorouracil and interferon-alpha in operable squamous cell carcinoma of the esophagus.
Bazarbashi S; Abdelsalam M; Amin T; El-Bassiouni M; Soudy H; Elweshi A; Alhusseiny H; Rehman K; Memon M; Ajarim D
Chemotherapy; 2008; 54(4):315-22. PubMed ID: 18701820
[TBL] [Abstract][Full Text] [Related]
12. Vinorelbine and cisplatin in advanced squamous cell carcinoma of the cervix: the South African experience.
Goedhals L; Falkson G; Smith BL; Falkson CI; Gasmi J; Lategan A; Burillon JP; His P
Anticancer Res; 2005; 25(3c):2489-92. PubMed ID: 16080481
[TBL] [Abstract][Full Text] [Related]
13. Treatment of advanced or recurrent squamous cell carcinoma of the uterine cervix with mitomycin-C, bleomycin, and cisplatin chemotherapy.
Smith HO; Stringer CA; Kavanagh JJ; Gershenson DM; Edwards CL; Wharton JT
Gynecol Oncol; 1993 Jan; 48(1):11-5. PubMed ID: 7678571
[TBL] [Abstract][Full Text] [Related]
14. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix--final results of a prospective phase II-study.
Vrdoljak E; Omrcen T; Novaković ZS; Jelavić TB; Prskalo T; Hrepić D; Hamm W
Gynecol Oncol; 2006 Nov; 103(2):494-9. PubMed ID: 16814371
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of cisplatin and vinorelbine in squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Morris M; Blessing JA; Monk BJ; McGehee R; Moore DH
J Clin Oncol; 2004 Aug; 22(16):3340-4. PubMed ID: 15310778
[TBL] [Abstract][Full Text] [Related]
16. Systemic chemotherapy with cisplatin plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): efficacy and safety of a lower dose of PF (80/800) at a single institution in Japan.
Kiyota N; Tahara M; Kadowaki S; Fuse N; Doi T; Minami H; Ohtsu A
Jpn J Clin Oncol; 2009 Apr; 39(4):225-30. PubMed ID: 19211574
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy of advanced squamous carcinoma of the cervix: a phase I-II study of high-dose cisplatin and cyclophosphamide. A pilot study of the Gynecologic Oncology Group.
Jobson VW; Muss HB; Thigpen JT; Homesley HD; Bundy B
Am J Clin Oncol; 1984 Aug; 7(4):341-5. PubMed ID: 6540048
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of topotecan and paclitaxel for recurrent, persistent, or metastatic cervical carcinoma.
Tiersten AD; Selleck MJ; Hershman DL; Smith D; Resnik EE; Troxel AB; Brafman LB; Shriberg L
Gynecol Oncol; 2004 Feb; 92(2):635-8. PubMed ID: 14766258
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
[TBL] [Abstract][Full Text] [Related]
20. Weekly cisplatin, infusional high-dose 5-fluorouracil and leucovorin for advanced, recurrent and metastatic cervical carcinoma.
Hsiao SM; Chen CA; Hsu C; Lin HH; Hsieh CY; Wei LH
Anticancer Res; 2008; 28(3B):1887-91. PubMed ID: 18630476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
